Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIOBIO: Biomarker Trial for RA Biologics Response
NCT01638715Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- May 2012
- Primary completion
- Aug 2018
- Modality
- Antibody Conjugates, Engineered Antibody Formats, Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 4 trial of infliximab, abatacept, tocilizumab, rituximab in rheumatoid arthritis (RA), sponsored by Medical University of Vienna. Started May 2012; status: completed.
02
Drugs
infliximababatacepttocilizumabrituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01638715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01638715.